Kelly Patton-Boyd
Family · Indianapolis, INNPI 1912531948
Payments from drug & device makers
Across 246 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$969
- Lilly USA, LLC$679
- AstraZeneca$587
- AbbVie$546
- Amarin Pharma, Inc.$346
- Amgen$227
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,451100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 40 | $969 |
| Lilly USA, LLC | 47 | $679 |
| AstraZeneca | 25 | $587 |
| AbbVie | 43 | $546 |
| Amarin Pharma, Inc. | 21 | $346 |
| Amgen | 11 | $227 |
| Exact Sciences | 8 | $184 |
| Phathom Pharmaceuticals, Inc. | 8 | $173 |
| Boehringer Ingelheim | 11 | $160 |
| Novartis | 6 | $102 |
| Dexcom, Inc. | 4 | $93 |
| Astellas Pharma US Inc | 5 | $88 |
| Azurity Pharmaceuticals, Inc. | 3 | $50 |
| Nevro Corp. | 2 | $35 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| UCB, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Novo Nordisk | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Pfizer | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
How this compares
$4,451 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 19 | $27,946 |
| JardianceEmpagliflozin | 13 | $14,600 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $875 |
| Pregabalin | 27 | $585 |
| Rosuvastatin Calcium | 20 | $386 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $366 |
| Atorvastatin Calcium | 17 | $223 |
| Amlodipine Besylate | 31 | $181 |
| Levothyroxine Sodium | 20 | $166 |
| Gabapentin | 13 | $114 |
| Methylprednisolone | 16 | $105 |
| Metformin Hcl | 14 | $80 |
| Levocetirizine Dihydrochloride | 11 | $74 |
| Furosemide | 17 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $587 | $27,94619 claims |
| Boehringer IngelheimJardiance | $160 | $14,60013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.
Other family in Indianapolis
- Tina SizemoreIndianapolis$888K
- Marla MosesIndianapolis$142K
- Leslye FisherIndianapolis$73K
- Alicia WettrickIndianapolis$72K
- Christine BaltIndianapolis$30K
- Kathryn KennedyIndianapolis$29K
- Andrea RandallIndianapolis$27K
- Deidre ArmsIndianapolis$26K
- Carrie GravesIndianapolis$16K
- Dominique LevequeIndianapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.